Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India

Current Indian guidelines recommend twice-annual CD4 testing to monitor first-line antiretroviral therapy (ART), with a plasma HIV RNA test to confirm failure if CD4 declines, which would prompt a switch to second-line ART. We used a mathematical model to assess the clinical benefits and cost-effect...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:AIDS Res Hum Retroviruses
Autores principales: Freedberg, Kenneth A., Kumarasamy, Nagalingeswaran, Borre, Ethan D., Ross, Eric L., Mayer, Kenneth H., Losina, Elena, Swaminathan, Soumya, Flanigan, Timothy P., Walensky, Rochelle P.
Formato: Artigo
Lenguaje:Inglês
Publicado: Mary Ann Liebert, Inc. 2018
Materias:
Clinical Studies
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5994680/
https://ncbi.nlm.nih.gov/pubmed/29620932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2017.0258
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares